BAMS
Bellevue Asset Management (Switzerland) Portfolio holdings
AUM
$656M
This Quarter Return
+10.91%
1 Year Return
+11.48%
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$656M
AUM Growth
+$656M
(+7%)
Cap. Flow
-$2.4M
Cap. Flow
% of AUM
-0.37%
Top 10 Holdings %
Top 10 Hldgs %
31%
Holding
140
New
7
Increased
41
Reduced
25
Closed
13
Top Buys
| 1 |
Cardinal Health
CAH
|
$8.17M |
| 2 |
Centene
CNC
|
$5.64M |
| 3 |
Viatris
VTRS
|
$4.88M |
| 4 |
Eagle Bancorp
EGBN
|
$4.88M |
| 5 |
LCI
Lannett Company, Inc.
LCI
|
$4.31M |
Top Sells
| 1 |
AGN
Allergan plc
AGN
|
$13.6M |
| 2 |
Dr. Reddy's Laboratories
RDY
|
$8.31M |
| 3 |
KITE
Kite Pharma, Inc.
KITE
|
$6.5M |
| 4 |
Abbott
ABT
|
$3.66M |
| 5 |
Tenet Healthcare
THC
|
$3.53M |
Sector Composition
| 1 | Healthcare | 93.1% |
| 2 | Financials | 1.62% |
| 3 | Industrials | 0.28% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Jazz Pharmaceuticals
JAZZ
$7.75B
| $8.43M | 1.29% |
60,000
+4,000
| +7% | +$562K |
|
27
Vertex Pharmaceuticals
VRTX
$100B
| $8.43M | 1.28% |
67,000
-15,500
| -19% | -$1.95M |
|
|
STJ
28
DELISTED
St Jude Medical
STJ
| $7.54M | 1.15% |
122,000
| – | – |
|
29
Cigna
CI
$80.3B
| $7.02M | 1.07% |
48,000
-10,000
| -17% | -$1.46M |
|
|
30
Centene
CNC
$14.3B
| $6.95M | 1.06% |
105,630
+85,630
| +428% | +$5.64M |
|
31
BioMarin Pharmaceuticals
BMRN
$11.2B
| $6.81M | 1.04% |
65,000
| – | – |
|
|
INSY
32
DELISTED
Insys Therapeutics, Inc.
INSY
| $6.64M | 1.01% |
232,000
+22,000
| +10% | +$630K |
|
33
Cencora
COR
$56.5B
| $6.64M | 1.01% |
64,000
+4,000
| +7% | +$415K |
|
34
Perrigo
PRGO
$3.27B
| $6.37M | 0.97% |
44,000
+4,000
| +10% | +$579K |
|
|
SHPG
35
DELISTED
Shire pic
SHPG
| $6.32M | 0.96% |
30,820
-70
| -0.2% | -$14.4K |
|
36
Intuitive Surgical
ISRG
$170B
| $6.31M | 0.96% |
11,550
-2,000
| -15% | -$1.09M |
|
37
Coherus Oncology, Inc. Common Stock
CHRS
$135M
| $5.9M | 0.9% |
257,000
+27,000
| +12% | +$620K |
|
|
AET
38
DELISTED
Aetna Inc
AET
| $5.73M | 0.87% |
53,000
| – | – |
|
39
Halozyme
HALO
$8.56B
| $5.51M | 0.84% |
318,000
+72,000
| +29% | +$1.25M |
|
40
Edwards Lifesciences
EW
$47.8B
| $5.45M | 0.83% |
69,000
+24,500
| +55% | +$1.94M |
|
41
Humana
HUM
$36.5B
| $5.36M | 0.82% |
30,000
| – | – |
|
|
HZNP
42
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $5.31M | 0.81% |
245,000
+25,000
| +11% | +$542K |
|
43
Alkermes
ALKS
$4.78B
| $5.2M | 0.79% |
65,500
+6,500
| +11% | +$516K |
|
44
Johnson & Johnson
JNJ
$427B
| $5.14M | 0.78% |
50,000
| – | – |
|
|
BCR
45
DELISTED
CR Bard Inc.
BCR
| $5.12M | 0.78% |
27,000
+2,500
| +10% | +$474K |
|
|
MNK
46
DELISTED
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
| $5.08M | 0.77% |
68,000
-12,000
| -15% | -$896K |
|
|
XENT
47
DELISTED
Intersect ENT, Inc
XENT
| $5.06M | 0.77% |
225,000
+25,223
| +13% | +$568K |
|
|
48
Eagle Bancorp
EGBN
$590M
| $4.88M | 0.74% |
+55,000
| New | +$4.88M |
|
49
Supernus Pharmaceuticals
SUPN
$2.53B
| $4.77M | 0.73% |
355,000
+35,000
| +11% | +$470K |
|
50
Community Health Systems
CYH
$387M
| $4.63M | 0.71% |
174,440
+12,100
| +7% | +$321K |
|